TIMP1 and colorectal carcinoma: In addition, regarding the role of pretreatment serum/plasma TIMP-1 levels in response to chemotherapy in CRC patients, high serum/plasma TIMP-1 levels tended to have higher numerical values of the pooled HR for CRC survival in the nonchemotherapy group, however, this difference was not statistically significant between the groups.